USFDA issues warning letter to Indoco Remedies’ Goa plantPost published:April 12, 2017Post category:Industry NewsUSFDA inspectors found significant violations of manufacturing practice regulations for finished pharmaceuticals at Indoco Remedies after inspecting it last year Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostCarlsberg India launches new beer Tuborg Classic Next PostApple’s Make in India tax demands rejected due to GST, says minister You Might Also Like Iridium Completes Historic $3 Billion Satellite Constellation Upgrade February 22, 2019 Number of taxpayers under GST set to eclipse that of previous tax regime July 24, 2017 An Introduction to Statistical Process Control (SPC) October 9, 2019